Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Hypertrophic Cardiomyopathy-Need for Gene-Specific Treatment?-Reply.

Coats CJ, Frenneaux MP, Elliott PM.

JAMA Cardiol. 2019 Jun 12. doi: 10.1001/jamacardio.2019.1766. [Epub ahead of print] No abstract available.

PMID:
31188395
2.

Effect of Trimetazidine Dihydrochloride Therapy on Exercise Capacity in Patients With Nonobstructive Hypertrophic Cardiomyopathy: A Randomized Clinical Trial.

Coats CJ, Pavlou M, Watkinson OT, Protonotarios A, Moss L, Hyland R, Rantell K, Pantazis AA, Tome M, McKenna WJ, Frenneaux MP, Omar R, Elliott PM.

JAMA Cardiol. 2019 Mar 1;4(3):230-235. doi: 10.1001/jamacardio.2018.4847.

PMID:
30725091
3.

Proteomic Analysis of the Myocardium in Hypertrophic Obstructive Cardiomyopathy.

Coats CJ, Heywood WE, Virasami A, Ashrafi N, Syrris P, Dos Remedios C, Treibel TA, Moon JC, Lopes LR, McGregor CGA, Ashworth M, Sebire NJ, McKenna WJ, Mills K, Elliott PM.

Circ Genom Precis Med. 2018 Dec;11(12):e001974. doi: 10.1161/CIRCGEN.117.001974.

PMID:
30562113
4.

The vital role of exercise testing in hypertrophic cardiomyopathy.

Coats CJ.

Int J Cardiol. 2018 Nov 15;271:200-201. doi: 10.1016/j.ijcard.2018.06.028. Epub 2018 Jun 7. No abstract available.

PMID:
29921517
5.

Arrhythmogenic right ventricular cardiomyopathy in Boxer dogs: the diagnosis as a link to the human disease.

Vischer AS, Connolly DJ, Coats CJ, Fuentes VL, McKenna WJ, Castelletti S, Pantazis AA.

Acta Myol. 2017 Sep 1;36(3):135-150. eCollection 2017 Sep.

6.

Papillary fibroelastoma arising from left ventricular outflow tract.

Coats CJ, Reid J, Wright S, Sonecki P, Al-Attar N.

Eur Heart J Cardiovasc Imaging. 2018 Jul 1;19(7):826. doi: 10.1093/ehjci/jey044. No abstract available.

PMID:
29608686
7.

Peripartum cardiomyopathy: diagnosis and management.

Jackson AM, Dalzell JR, Walker NL, Coats CJ, Jhund PS, Petrie MC.

Heart. 2018 May;104(9):779-786. doi: 10.1136/heartjnl-2016-310599. Epub 2017 Nov 9. No abstract available.

PMID:
29122930
8.

CardioScape mapping the cardiovascular funding landscape in Europe.

Pries AR, Naoum A, Habazettl H, Dunkel M, Preissner R, Coats CJ, Tornada A, Orso F, Van de Werf F, Wood DA; CardioScape steering committee, Van de Werf F, Wood DA, O'Kelly S, Craven J, Coats A, Sipido K, De Backer D, Wallentin L, Hasenfuss G, Della Sala L, Leggeri I; CardioScape scientific committee, Wood DA, Van de Werf F, Jaarsma T, Elliott P, Pries AR, Madonna R, Kjeldsen K, Maggioni AP, Franco OH, Hills S, Pugliese F, De Bacquer D.

Eur Heart J. 2018 Jul 1;39(25):2423-2430. doi: 10.1093/eurheartj/ehx106.

PMID:
28449050
9.

Cardiopulmonary Exercise Testing and Prognosis in Hypertrophic Cardiomyopathy.

Coats CJ, Rantell K, Bartnik A, Patel A, Mist B, McKenna WJ, Elliott PM.

Circ Heart Fail. 2015 Nov;8(6):1022-31. doi: 10.1161/CIRCHEARTFAILURE.114.002248. Epub 2015 Sep 15.

PMID:
26374874
10.

Current applications of biomarkers in cardiomyopathies.

Coats CJ, Heywood WE, Mills K, Elliott PM.

Expert Rev Cardiovasc Ther. 2015;13(7):825-37. doi: 10.1586/14779072.2015.1053873. Review.

PMID:
26106935
11.

Calculated plasma volume status and prognosis in chronic heart failure.

Ling HZ, Flint J, Damgaard M, Bonfils PK, Cheng AS, Aggarwal S, Velmurugan S, Mendonca M, Rashid M, Kang S, Papalia F, Weissert S, Coats CJ, Thomas M, Kuskowski M, Cohn JN, Woldman S, Anand IS, Okonko DO.

Eur J Heart Fail. 2015 Jan;17(1):35-43. doi: 10.1002/ejhf.193. Epub 2014 Dec 3.

12.

Genetic biomarkers in hypertrophic cardiomyopathy.

Coats CJ, Elliott PM.

Biomark Med. 2013 Aug;7(4):505-16. doi: 10.2217/bmm.13.79. Review.

PMID:
23905887
13.

Relation between serum N-terminal pro-brain natriuretic peptide and prognosis in patients with hypertrophic cardiomyopathy.

Coats CJ, Gallagher MJ, Foley M, O'Mahony C, Critoph C, Gimeno J, Dawnay A, McKenna WJ, Elliott PM.

Eur Heart J. 2013 Aug;34(32):2529-37. doi: 10.1093/eurheartj/eht070. Epub 2013 Mar 1.

PMID:
23455360
14.

Expansion of the red cell distribution width and evolving iron deficiency as predictors of poor outcome in chronic heart failure.

Aung N, Ling HZ, Cheng AS, Aggarwal S, Flint J, Mendonca M, Rashid M, Kang S, Weissert S, Coats CJ, Richards T, Thomas M, Woldman S, Okonko DO.

Int J Cardiol. 2013 Oct 3;168(3):1997-2002. doi: 10.1016/j.ijcard.2012.12.091. Epub 2013 Jan 22.

PMID:
23351789
15.

Role of serum N-terminal pro-brain natriuretic peptide measurement in diagnosis of cardiac involvement in patients with anderson-fabry disease.

Coats CJ, Parisi V, Ramos M, Janagarajan K, O'Mahony C, Dawnay A, Lachmann RH, Murphy E, Mehta A, Hughes D, Elliott PM.

Am J Cardiol. 2013 Jan 1;111(1):111-7. doi: 10.1016/j.amjcard.2012.08.055. Epub 2012 Oct 4.

PMID:
23040658
16.

A case of transient hypertrophic cardiomyopathy.

Cahill TJ, Coats CJ, Elliott PM.

Postgrad Med J. 2010 May;86(1015):310-2. doi: 10.1136/pgmj.2009.092353. Epub 2010 Apr 3. No abstract available.

PMID:
20364034
17.

Arrhythmogenic left ventricular cardiomyopathy.

Coats CJ, Quarta G, Flett AS, Pantazis AA, McKenna WJ, Moon JC.

Circulation. 2009 Dec 22;120(25):2613-4. doi: 10.1161/CIRCULATIONAHA.109.874628. No abstract available.

PMID:
20026794
18.

Current management of hypertrophic cardiomyopathy.

Coats CJ, Elliott PM.

Curr Treat Options Cardiovasc Med. 2008 Dec;10(6):496-504.

PMID:
19026180
19.

Hypertrophic cardiomyopathy: lessons from history.

Coats CJ, Hollman A.

Heart. 2008 Oct;94(10):1258-63. doi: 10.1136/hrt.2008.153452. Epub 2008 Jul 24.

PMID:
18653579

Supplemental Content

Loading ...
Support Center